RMD - Earnings announcements

Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%GAAP income from operations increased 17%; non-GAAP income from operations up 18%GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86Operating cash flow of $554 million; $262 million returned to shareholders through share repurchases and dividends Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE:RMD, ASX: RMD)) today announced results for its quarter ended March 31, 2026.

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:https://investor.resmed.com•Date:1:30 p.m. PT / 4:30 p.m. ET•Time:London, Thursday, April 30, 2026, 9:30 p.m. BST•International:Sydney, Friday, May 1, 2026, 6:30 a.m. AEST    Please note, Resmed does not use outside phone lines t

Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP income from operations up 19%Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81Operating cash flow of $340 million Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE:RMD, ASX: RMD)) today announced results for its quarter ended December 31, 2025. "Our second quarter results demonstrate the strength and resilience of our global business a

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:•Location:https://investor.resmed.com•Date:Thursday, January 29, 2026•Time:1:30 p.m. PST / 4:30 p.m. EST•International:London, Thursday, January 29, 2026, 9:30 p.m. GMT  Sydney, Friday, January 30, 2026, 8:30 a.m. AEDT Please note, Resmed

Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0%Income from operations increased 15%; non-GAAP income from operations up 19%Diluted earnings per share of $2.37; non-GAAP diluted earnings per share of $2.55Operating cash flow of $457 million Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE:RMD, ASX: RMD)) today announced results for its quarter ended September 30, 2025. "Our fiscal year 2026 is off to a strong start, with first-quarter performance r

SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  •Location:https://investor.resmed.com •Date:Thursday, October 30, 2025 •Time:1:30 p.m. PDT / 4:30 p.m. EDT •International:London, Thursday, October 30, 2025, 8:30 p.m. GMTSydney, Friday, October 31, 2025, 7:30 a.m. AEDT     Please note,

Year-over-year revenue grows 10%, operating profit up 19%, non-GAAP operating profit up 19%Operating cash flow of $539 millionQuarterly dividend increases 13% to $0.60 per share Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE:RMD, ASX: RMD)) today announced results for its quarter ended June 30, 2025. Fourth Quarter 2025 HighlightsAll comparisons are to the prior year period Revenue increased by 10% to $1.3 billion; up 9% on a constant currency basis Gross margin improved 230 bps to 60.8%; non-GAAP gross margin improved 230 bps to 61.4

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  •Location:https://investor.resmed.com •Date:Thursday, July 31, 2025 •Time:1:30 p.m. PDT / 4:30 p.m. EDT •International:London, Thursday, July 31, 2025, 9:30 p.m. BSTSydney, Friday, August 1, 2025, 6:30 a.m. AEST     Please note, Resmed

Year-over-year revenue grows 8%, operating profit up 14%, non-GAAP operating profit up 13%Operating cash flow of $579 million Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE:RMD, ASX: RMD)) today announced results for its quarter ended March 31, 2025. Third Quarter 2025 HighlightsAll comparisons are to the prior year period Revenue increased by 8% to $1.3 billion; up 9% on a constant currency basis Gross margin improved 140 bps to 59.3%; non-GAAP gross margin improved 140 bps to 59.9%Income from operations increased 14%; non-GAAP income from operations up 13

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  •Location:https://investor.resmed.com •Date:Wednesday, April 23, 2025 •Time:1:30 p.m. PDT / 4:30 p.m. EDT •International:London, Wednesday, April 23, 2025, 9:30 p.m. BST   Sydney, Thursday, April 24, 2025, 6:30 a.m. AEST Please note,

Year-over-year revenue grows 10%, operating profit up 52%, non-GAAP operating profit up 19%Operating cash flow of $309 million Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD)) today announced results for its quarter ended December 31, 2024. Second Quarter 2025 HighlightsAll comparisons are to the prior year period Revenue increased by 10% to $1.3 billion; up 10% on a constant currency basis Gross margin improved 300 bps to 58.6%; non-GAAP gross margin improved 230 bps to 59.2%Income from operations increased 52%; non-GAAP income from operations

SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:https://investor.resmed.com• Date:Thursday, January 30, 2025• Time:1:30 p.m. PST / 4:30 p.m. EST• International:London, Thursday, January 30, 2025, 9:30 p.m. GMT Sydney, Friday, January 31, 2025, 8:30 a.m. AEDT   Please no

Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27%Operating cash flow of $326 million Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended September 30, 2024. First Quarter 2025 HighlightsAll comparisons are to the prior year period Revenue increased by 11% to $1.2 billion; up 11% on a constant currency basis Gross margin improved 420 bps to 58.6%; non-GAAP gross margin improved 320 bps to 59.2%Income from operations increased 34%; non-GAAP income from operation

SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date: Thursday, October 24, 2024 Time: 1:30 p.m. PDT / 4:30 p.m. EDT International: London, Thursday, October 24, 2024, 9:30 p.m. BSTSydney, Friday, October 25, 2024, 7:30 a.m.

Year-over-year revenue grows 9%, operating profit up 38%, non-GAAP operating profit up 30%Operating cash flow of $440 millionQuarterly dividend increases 10% to $0.53 per shareCompany to host an Investor Day on September 30, 2024 Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended June 30, 2024. Fourth Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 9% to $1.2 billion; up 10% on a constant currency basis Gross margin improved 350 bps to 58.5%; non-GAAP gross ma

SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2024 on Thursday, August 1, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:   Location: http://investor.resmed.com  Date: Thursday, August 1, 2024  Time: 1:30 p.m. PDT / 4:30 p.m. EDT  International: London, Thursday, August 1,

Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended March 31, 2024. Third Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 7% to $1.2 billion; up 7% on a constant currency basis Gross margin grew 260 bps to 57.9%; non-GAAP gross margin grew 240 bps to 58.5%Income from operations increased 25%; non-GAAP operating profit u

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  • Location:http://investor.resmed.com • Date:Thursday, April 25, 2024 • Time:1:30 p.m. PDT / 4:30 p.m. EDT • International:London, Thursday, April 25, 2024, 9:30 p.m. BSTSydney, Friday, April 26, 2024, 6:30 a.m. AEST    Please note, ResM

Year-over-year revenue grows 12%, operating profit down 2%, non-GAAP operating profit up 20%Resumed share repurchase program, repurchased $50 million during quarter Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended December 31, 2023. Second Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $1.2 billion; up 11% on a constant currency basis Gross margin contracted 50 bps to 55.6%; non-GAAP gross margin grew 10 bps to 56.9%Income from operations decreased 2

SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday, January 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •  Location:http://investor.resmed.com•  Date:Wednesday, January 24, 2024•  Time:1:30 p.m. PST / 4:30 p.m. EST•  International:London, Wednesday, January 24, 2024, 9:30 p.m. GMT Sydney, Thursday, January 25, 2024, 8:30 a.m. AEDT Please

Year-over-year revenue grows 16%, operating profit up 5%, non-GAAP operating profit up 10%Expects to resume its share repurchase program during upcoming quarter Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended September 30, 2023. First Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 16% to $1.1 billion; up 15% on a constant currency basis Gross margin contracted 250 bps to 54.4%; non-GAAP gross margin contracted 160 bps to 56.0%Income from operations increas

SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, October 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:http://investor.resmed.com•Date:Thursday, October 26, 2023•Time:1:30 p.m. PDT / 4:30 p.m. EDT•International:London, Thursday, October 26, 2023, 9:30 p.m. BSTSydney, Friday, October 27, 2023, 7:30 a.m. AEDT Please note, ResM

Year-over-year revenue grows 23%, operating profit up 8%, non-GAAP operating profit up 13%Quarterly dividend increases 9% to $0.48 per share Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended June 30, 2023. Fourth Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 23% to $1.1 billion; up 23% on a constant currency basis Gross margin contracted 210 bps to 55.0%; non-GAAP gross margin contracted 200 bps to 55.8%Income from operations increased 8%; non-GAAP 

SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  • Location:http://investor.resmed.com • Date: Thursday, August 3, 2023 • Time:1:30 p.m. PDT / 4:30 p.m. EDT • International:London, Thursday, August 3, 2023, 9:30 p.m. BST    Sydney, Friday, August 4, 2023, 6:30 a.m. AEST Please note, Re

Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended March 31, 2023. Third Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 29% to $1,116.9 million; up 31% on a constant currency basis Gross margin contracted 150 bps to 55.3%; non-GAAP gross margin contracted 200 bps to 56.1%Income from operations increased 28%; non-GAAP operating profit up 27%Operating cash flow of $282.6 millionDiluted earnings per share of $1.58; non-GAAP diluted earnings per share of $1.68 "

SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:http://investor.resmed.com•Date:Thursday, April 27, 2023•Time:1:30 p.m. PDT / 4:30 p.m. EDT•International:London, Thursday, April 27, 2023, 9:30 p.m. BST  Sydney, Friday, April 28, 2023, 6:30 a.m. AEST Please note, ResMed does n

Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended December 31, 2022. Second Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 16% to $1,033.7 million; up 20% on a constant currency basis Gross margin contracted 30 bps to 56.1%; non-GAAP gross margin contracted 80 bps to 56.8%Income from operations increased 13%; non-GAAP operating profit up 14%Diluted earnings per share

SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday, January 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date: Thursday, January 26, 2023 Time: 1:30 p.m. PDT / 4:30 p.m. EDT International: London, Thursday, January 26, 2023, 9:30 p.m. GMT Sydney, Friday, January 27, 2023, 8:30 a.m. AEDT Please note: Re

Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended September 30, 2022. First Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 5% to $950.3 million; up 9% on a constant currency basis Gross margin expanded by 90 bps to 56.9%; non-GAAP gross margin expanded by 40 bps to 57.6%Income from operations increased 5%; non-GAAP operating profit up 4%Diluted earnings per share of $1.4

SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday, October 27, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: • Location: http://investor.resmed.com• Date: Thursday, October 27, 2022• Time: 1:30 p.m. PDT / 4:30 p.m. EDT• International:London, Thursday, October 27, 9:30 p.m. BST   Sydney, Friday, October 28, 7:30 a.m. AEDT Please note that Res

Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP operating profit up 4%Quarterly dividend increases 5% to $0.44 per share Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended June 30, 2022. Fourth Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 4% to $914.7 million; up 8% on a constant currency basis Gross margin grew 110 bps to 57.1%; non-GAAP gross margin grew 50 bps to 57.8%Income from operations increased 6%; non-GAAP operating profit up 4%D

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: • Location:http://investor.resmed.com• Date:Thursday, August 11, 2022• Time:1:30 p.m. PDT / 4:30 p.m. EDT• International:London, Thursday, August 11, 9:30 p.m. BSTSydney, Friday, August 12, 6:30 a.m. AEST Please note that ResMed d

Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended March 31, 2022. Third Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $864.5 million; up 14% on a constant currency basis Gross margin contracted 140 bps to 56.8%; non-GAAP gross margin contracted 150 bps to 58.1%Income from operations increased 5%; non-GAAP operating profit up 5%Diluted earnings per share of $1.2

SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: •Location:http://investor.resmed.com•Date:Thursday, April 28, 2022•Time:1:30 p.m. PDT / 4:30 p.m. EDT•International:London, Thursday, April 28, 9:30 p.m. BST  Sydney, Friday, April 29, 6:30 a.m. AEST Please note that ResMed does not us

Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))) today announced results for its quarter ended December 31, 2021. Second Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $894.9 million; up 13% on a constant currency basisGross margin of 56.4%; non-GAAP gross margin contracted 230 bps to 57.6%Income from operations increased 12%; non-GAAP operating profit up 5%Diluted earnings per share of $1.37; non-GAAP dil

SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on Thursday, January 27, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: •Location:http://investor.resmed.com•Date:  Thursday, January 27, 2022•Time:1:30 p.m. PST / 4:30 p.m. EST•International:London, Thursday, January 27, 9:30 p.m. GMT  Sydney, Friday, January 28, 8:30 a.m. AEDT Please note that ResMed d

Year-over-year revenue grows 20%, operating profit up 21%, non-GAAP operating profit up 18% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))), a world-leading digital health company, today announced results for its quarter ended September 30, 2021. First Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 20% to $904.0 million; up 19% on a constant currency basisGross margin of 56.0%; non-GAAP gross margin contracted 270 bps to 57.2%Income from operations increased 21%; non-GAAP operating pro

SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD))) today announced it plans to release financial and operational results for the first quarter of fiscal year 2022 on Thursday, October 28, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details:•Location:http://investor.resmed.com•Date:Thursday, October 28, 2021•Time:1:30 p.m. PDT / 4:30 p.m. EDT•International:London, Thursday, October 28, 9:30 p.m. BST  Sydney, Friday, October 29, 7:30 a.m. AEDT    Please note that ResMed d

Year-over-year revenue grows 14%, operating profit up 8%, non-GAAP operating profit up 7%Quarterly dividend increases 8% to $0.42 per shareCompany to host a virtual Investor Day on September 8, 2021, at 1:30 p.m. PT Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))), a world-leading digital health company, today announced results for its quarter ended June 30, 2021. Fourth Quarter 2021 HighlightsAll comparisons are to the prior year period Revenue increased by 14% to $876.1 million; up 10% on a constant currency basisGross margin of 56.0%; non-G